The notification in this regard has been issued on July 10 by NPPA. Paragraph 19 of DPCO 2013, empowers the NPPA to fix the ceiling prices of any drug marketed in the country for any period if the ...

“NPPA has fixed/ revised ceiling prices of 22 scheduled formulations of Schedule-I under Drugs (Price Control) Amendment Order, 2016 and retail price of 13 formulations under DPCO, 2013,” the ...

NEW DELHI, Jun 13: Taking a serious view of non-compliance of DPCO, 2013, the National Pharmaceutical Pricing Authority (NPPA) has issued notices to major drug firms for failing to register ...

As stipulated under the Drugs (Prices Control) Order (DPCO) 2013, NPPA fixes the ceiling price of essential medicines of Schedule I. The calculation of price for essential drugs is based on the ...

“After detailed deliberations in the full authority meeting held on October 8 invoking extraordinary powers under Para 19 of the DPCO, 2013, and in the larger public interest, NPPA has approved ...

NPPA fixes ceiling and retail prices of essential medicines of Schedule I under the Drugs (Prices Control) Order (DPCO) 2013. It also monitors annual price increase for these and the non-scheduled ...

This is being done as “the objective of the DPCO 2013 is that the government should in due course come out with an appropriate mechanism of obtaining market-based data related to drugs," NPPA said.

Therefore, as a special case of drug being mainly sold to diagnostic centres and hospital, NPPA may utilise the powers given to it under paras 9(1) and 9(7) of DPCO, 2013 to explore other database to ...

Usually, NPPA goes for price capping only when a drug or device is included in schedule-I of DPCO 2013. All drugs included in the NLEM are notified as schedule-I drugs. The price capping of stents ...

Under DPCO 2013, a manufacturer is required to inform NPPA at least six months prior to the intended date of discontinuation and also “follow ceiling price in such a manner and till such a time ...